Skip to Content

Lidocaine 1% Preservative-Free Injection

Last Updated: May 19, 2011
Status: Resolved

Products Affected - Description

Xylocaine 1% Preservative-Free Injection, APP
10 mg/mL 30 mL vial (NDC 63323-0492-30) - discontinued
10 mg/mL 5 mL vial (NDC 63323-0492-05) - discontinued

Reason for the Shortage

  • Hospira’s lidocaine 1% injection presentations were on back order due to a supply interruption.
  • APP states the shortage was due to increased demand for product. Also, APP is transitioning to new packaging with new NDC numbers for several Xylocaine products.

Estimated Resupply Dates

  • APP has available Xylocaine 1% preservative-free 10 mg/mL injection 2 mL vials (NDC 63323-04-92-02) 5 mL (NDC 63323-0492-89) ampules, 5 mL vials (NDC 63323-0492-57), 30 mL single-dose vials (NDC 63323-0492-37), 30 mg sterile pack vials (NDC 63323-0492-31), and 2 mL (NDC 63323-0492-80) ampules.
  • Hospira has available lidocaine 1% preservative-free injection 2 mL ampules (NDC 63323-0492-02). Lidocaine 1% preservative-free 30 mL single-dose vials (NDC 00409-4279-02), 30 mL sterile pack vials (NDC 00409-4270-01), and 5 mL ampules (NDC 00409-4713-02) are available. The company also has available Lidocaine 1% 5 mL Ansyr syringes (NDC 00409-9137-05) and 5 mL Lifeshield Abboject syringes (NDC 00409-4904-34).

Related Shortages

Updated

May 19, 2011; May 12, 2011; April 20, 2011; March 10, 2011; March 8, 2011; February 11, 2011; January 25, 2011; January 6, 2011, University of Utah, Drug Information Service. Copyright 2011, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide